Cytostatic 6-arylpurine nucleosides II. Synthesis of sugar-modified derivatives: 9-(2-deoxy-β-D-erythro-pentofuranosyl)-, 9-(5-deoxy-β-D-ribofuranosyl)- and 9-(2,3-dihydroxypropyl)-6-phenylpurines

Collection of Czechoslovak Chemical Communications

Volumn 65, Issue 11, 2000, Pages 1683-1697

  Hocek, Michal ^a   Holý, Antonín ^a   Votruba, Ivan ^a   Dvořáková, Hana ^b  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

2 Deoxyribonucleosides; 5 Deoxyribonucleosides; Acyclic nucleoside analogues; Antitumor agents; Boronic acids; Cross coupling reactions; Cytostatic activity; Nucleosides; Purines

Indexed keywords

EID: 23044526799     PISSN: 00100765     EISSN: None     Source Type: Journal    
DOI: 10.1135/cccc20001683     Document Type: Article

References (23)

1. Montgomery J. A., Hewson K: J. Med. Chem. 1968, 11, 48.
2. a) McGarrity G. J., Carson D. A.: Exp. Cell Res. 1982, 139, 199;
3. b) Whitaker A. M., Windsor G. D., Burnett C. M., Taylor C. H.: Dev. Biol. Stand. 1987, 66, 503;
4. c) Ishiguro K., Taira S., Sasaki T., Nariuchi H.: J. Immunol. Methods 1988, 108, 39.
5. a) Parker W. B., King S. A., Allan P. W., Bennett L. L., Jr., Secrist J. A., Montgomery J. A., Gilbert K. S., Waud W. R., Wells A. H., Gillespie G. Y., Sorscher E. J.: Hum. Gene Ther. 1997, 8, 1637;
6. b) Parker W. B., Allan P. W., Shaddix S. C., Rose, L. M., Speegle H. F., Gillespie G. Y., Bennett L. L., Jr.: Biochem. Pharmacol. 1998, 55, 1673.
7. Brathe A., Gundersen L. L., Rise F., Eriksen A. B., Vollsnes A. V., Wang L. N.: Tetrahedron 1999, 55, 211.
8. Hocková D., Hocek M., Dvořáková H., Votruba I.: Tetrahedron 1999, 55, 11109.
9. Cocuzza A. J., Chidester D. R., Culp S., Fitzgerald L., Gilligan P.: Bioorg. Med. Chem. Lett. 1999, 9, 1063.
10. Bakkestuen A. K., Gundersen L. L., Langli G., Liu F., Nolsøe J. M. J.: Bioorg. Med. Chem. Lett. 2000, 10, 1207.
11. Hocek M., Holý A., Votruba I., Dvořáková H.: J. Med. Chem. 2000, 43, 1817.
12. a) Hocek M., Masojídková M., Holý A.: Collect. Czech. Chem. Commun. 1997, 62, 136;
13. b) Česnek M., Hocek M., Holý A.: Collect. Czech. Chem. Commun. 2000, 65, 1357.
14. Plagemann P. G., Wohlhueter R. M.: Biochem. Pharmacol. 1983, 32, 1433.
15. Havelková M., Hocek M., Česnek M., Dvořák D.: Synlett 1999, 1145.
16. Hocek M., Holý A.: Collect. Czech. Chem. Commun. 1999, 64, 229.
17. Seela F., Winter H.: Nucleosides Nucleotides 1995, 14, 129.
18. Holý A., Rosenberg I., Dvořáková H.: Collect. Czech. Chem. Commun. 1989, 54, 2470.
19. Ramasamy K. S., Tam R. C., Bard J., Averett D. R.: J. Med. Chem. 2000, 43, 1019.
20. Hřebabecký H., Dočkal J., Holý A.: Collect. Czech. Chem. Commun. 1994, 59, 1408.
21. Wang G., Tam R. C., Gunic E., Du J., Bard J., Pai B.: J. Med. Chem. 2000, 43, 2566.
22. Schmidt R. R., Lösch G. R., Fischer P.: Chem. Ber. 1980, 113, 2891.
23. Vorbrüggen H. in: Nucleoside Analogues. Chemistry, Biology and Medical Applications (R. T. Walker, E. De Clercq and F. Eckstein, Eds), p. 35. Plenum Press, New York 1979.